Mumps: final-year medical student guide
1. Definition and why it still matters
Mumps is an acute, contagious systemic viral disease caused by the mumps virus, classically producing painful swelling of the parotid salivary glands. It can also affect the CNS, testes, ovaries, pancreas, cochlea, and other organs.
It is vaccine-preventable, but do not dismiss it in a person who received MMR. Outbreaks occur in highly vaccinated adolescents and young adults, especially in universities, sports teams, military settings, religious communities, and other close-contact environments. Waning immunity and intense exposure are contributing factors. A 2025 systematic review also identified vaccination gaps and close-contact settings as important outbreak determinants (
recent review).
One-line exam definition:
Mumps is an acute infection with an enveloped, negative-sense single-stranded RNA paramyxovirus, causing epidemic parotitis and potentially aseptic meningitis, orchitis, pancreatitis, and sensorineural hearing loss.
2. Virology
| Feature | What to know |
|---|
| Family | Paramyxoviridae |
| Virus | Mumps orthorubulavirus, formerly classed in the Rubulavirus genus |
| Genome | Enveloped, single-stranded, negative-sense RNA virus |
| Replication | Cytoplasmic |
| Surface proteins | HN protein binds sialic acid and has hemagglutinin-neuraminidase activity; F protein mediates membrane fusion and syncytium formation |
| Host | Humans only |
| Serotype | One serotype, although multiple genotypes exist |
| Environmental stability | Fragile enveloped virus, inactivated by heat, ultraviolet light, lipid solvents, drying, and disinfectants |
The virus enters through the respiratory tract, replicates locally and in regional lymph nodes, then produces viremia. It disseminates preferentially to the salivary glands, testes, ovaries, pancreas, and CNS.
The HN glycoprotein mediates upper-respiratory epithelial infection, while viral spread through virememia explains extra-salivary complications. T-cell responses are important both for viral clearance and for the inflammatory gland swelling. Medical Microbiology 9e, p. 778.
3. Epidemiology and transmission
Transmission
Spread is via:
- Respiratory droplets
- Saliva and direct close contact
- Contaminated respiratory secretions or fomites less commonly
Incubation period
- Average: 16-18 days
- Range: 12-25 days
Infectious period
A person is considered infectious from:
- 2 days before parotitis begins
- Through 5 days after onset of parotitis
Viral shedding can occur outside that interval, but infectivity is highest close to symptom onset. For infection-control purposes, use the 2-days-before to 5-days-after rule (
CDC clinical overview).
Important epidemiological facts
- In the pre-vaccine era, most people acquired mumps during childhood.
- Two-dose MMR programmes have reduced incidence dramatically.
- Cases can occur in people with two documented MMR doses.
- Breakthrough outbreaks do not mean MMR is ineffective. Mumps vaccine effectiveness is lower than the measles component, immunity can decline with time, and close, repeated exposure can overcome partial immunity.
4. Clinical presentation
A. Typical mumps
Prodrome
Often mild, lasts a few days:
- Low-grade fever
- Malaise and fatigue
- Headache
- Myalgia
- Anorexia
- Sore throat or nonspecific upper-respiratory symptoms
Parotitis
This is the hallmark finding.
- Painful swelling and tenderness of one or both parotid glands
- Usually begins on one side, then becomes bilateral in many patients
- May involve the submandibular or sublingual glands
- Swelling peaks over 1-3 days and usually settles over approximately 7-10 days
- Ear lobule is pushed upward and outward
- The angle of the mandible may be obscured
- Pain may increase with chewing or acidic foods due to salivary stimulation
Clinical distinction: parotid swelling is anterior and inferior to the ear. Cervical lymphadenopathy tends to be posterior to the angle of the jaw.
About 20-40% of infections may be asymptomatic. Others have nonspecific symptoms without parotitis. Absence of parotitis does not exclude mumps, especially when there is a compatible complication such as aseptic meningitis or orchitis. Goldman-Cecil Medicine, p. 3569.
5. Complications
Complications are more frequent in adults, particularly unvaccinated adults, but can occur in vaccinated people. They may occur with or without parotitis.
| System | Complication | Key facts |
|---|
| Genital | Orchitis | Most common complication in postpubertal males |
| CNS | Aseptic meningitis | Commonest neurologic complication |
| CNS | Encephalitis | Rare but dangerous |
| Ear | Sensorineural hearing loss | Usually unilateral and transient, rarely permanent |
| Pancreas | Pancreatitis | Abdominal pain and vomiting |
| Female genital/breast | Oophoritis, mastitis | May cause pelvic or breast pain |
| Other | Myocarditis, nephritis, arthritis, thyroiditis, thrombocytopenia | Uncommon |
A. Mumps orchitis
Who gets it?
- Primarily postpubertal males.
- Reported in approximately 15-35% of postpubertal males with mumps.
- Usually unilateral, but may be bilateral in roughly one-quarter of cases.
Timing
- Usually occurs around 1 week after parotitis.
- Can precede parotitis or occur without it.
Presentation
- Fever
- Acute testicular pain, swelling, erythema, and tenderness
- Scrotal edema
- Possible epididymal involvement
Outcome
- Pain and swelling usually improve in about a week, but tenderness can last longer.
- Testicular atrophy may develop.
- Permanent infertility is uncommon, although impaired spermatogenesis and subfertility may occur, especially with bilateral disease.
Critical clinical rule:
A painful swollen testis is testicular torsion until proven otherwise. Do not label it mumps orchitis without considering torsion. Urgent Doppler ultrasound and urological assessment are needed when torsion is possible.
Management
- Bed rest
- Scrotal elevation/support
- Cold packs
- NSAID or paracetamol
- Exclude torsion and bacterial epididymo-orchitis
- No routine antiviral or corticosteroid treatment
B. Oophoritis and mastitis
May cause lower abdominal/pelvic pain or breast inflammation in postpubertal women. Unlike orchitis, oophoritis has not been shown to cause infertility.
C. Aseptic meningitis
Mumps is neurotropic. CSF pleocytosis may occur even without neurological symptoms.
Typical features
- Headache
- Fever
- Neck stiffness
- Vomiting
- Photophobia
- Drowsiness
It commonly occurs around 4-5 days after parotitis, although it may be the presenting syndrome. CSF often shows lymphocytic pleocytosis, normal glucose, and normal or mildly raised protein.
Mumps meningitis is usually self-limiting, but it requires assessment because bacterial meningitis, HSV encephalitis, and other causes must be excluded initially. Harrison’s Principles of Internal Medicine 22e, p. 1692.
D. Encephalitis
Rare, but potentially fatal or associated with neurological sequelae.
Red flags
- Altered mental state
- Seizures
- Focal neurological deficit
- Aphasia
- Reduced consciousness
- Marked fever or deterioration
This requires admission, neuroimaging when indicated, lumbar puncture if safe, and empiric treatment for alternative treatable CNS infections while the diagnosis is being clarified.
E. Hearing loss
- Usually sudden, unilateral, and sensorineural
- May be transient
- May have tinnitus, vertigo, or other vestibular symptoms
- Permanent, particularly bilateral, deafness is rare but important
Any patient reporting reduced hearing, tinnitus, or vertigo needs urgent audiological and ENT evaluation.
F. Pancreatitis
Mumps pancreatitis is uncommon.
Suspect it with:
- Epigastric pain radiating to the back
- Persistent vomiting
- Abdominal tenderness
- Raised lipase
A raised amylase alone is not diagnostic because parotitis itself can elevate serum amylase. Lipase supports true pancreatic involvement. Harrison’s Principles of Internal Medicine 22e, p. 1691.
G. Pregnancy
Maternal mumps is generally not more severe than mumps in non-pregnant adults. Historical studies raised a possible association with early pregnancy loss, but evidence is limited and inconsistent. It is
not a proven teratogen in the way rubella is. Discuss the case with obstetrics and public health, offer routine obstetric assessment, and avoid unnecessary reassurance or alarmism (
CDC pregnancy summary).
6. Differential diagnosis of parotitis
A key final-year task is not simply recognizing mumps, but identifying alternative diagnoses that require different treatment.
| Diagnosis | Helpful distinguishing features |
|---|
| Mumps | Viral prodrome, tender uni/bilateral parotitis, exposure/outbreak context, no pus from duct |
| Acute bacterial suppurative parotitis | Toxic appearance, high fever, unilateral painful erythematous swelling, purulent discharge from Stensen duct, dehydration or frailty, commonly S. aureus |
| Sialolithiasis | Recurrent unilateral pain/swelling, worse during meals, stone or obstruction |
| Other viral parotitis | Influenza A H3N2, parainfluenza, EBV, CMV, adenovirus, HIV and enteroviruses |
| Dental infection | Local dental pain, gingival disease, focal dental findings |
| Cervical lymphadenitis | Discrete nodal swelling rather than salivary-gland enlargement |
| Sjögren syndrome | Chronic, often bilateral enlargement with dry eyes and dry mouth |
| Sarcoidosis | Chronic enlargement and systemic features |
| Tumour or cyst | Persistent painless unilateral mass |
| Drug/metabolic causes | Recurrent or chronic noninfective salivary enlargement |
Other viral and noninfective causes of parotitis must be considered, especially when the clinical or epidemiological context is not typical. Harrison’s Principles of Internal Medicine 22e, p. 1692.
7. Diagnosis
A. When to suspect mumps
Suspect it in a patient with:
- Acute unilateral or bilateral parotitis or other salivary-gland swelling
- A compatible prodrome
- Orchitis, oophoritis, aseptic meningitis, pancreatitis, or sudden hearing loss without another clear cause
- Exposure to a case or an outbreak setting
- Incomplete vaccination history
Do not exclude mumps because the patient has received MMR. Vaccination lowers risk and severity but does not exclude breakthrough infection.
B. First actions in suspected mumps
- Isolate using droplet precautions
- Notify local infection-control and public-health teams
- Obtain a focused history and examination for complications
- Collect diagnostic specimens promptly
- Do not wait for results before instituting isolation
C. Laboratory confirmation
Preferred test: rRT-PCR
- Obtain a buccal swab for real-time reverse-transcription PCR.
- Massage the parotid gland for about 30 seconds before swabbing to improve yield.
- Collect as early as possible after parotitis begins.
- Ideally collect in the first 0-3 days and within 10 days of onset.
Buccal swab rRT-PCR is preferred because it is rapid, specific, and useful for molecular surveillance. A negative result does
not rule out mumps, especially if collection was delayed or the patient was vaccinated (
CDC surveillance guidance).
Serology
- Serum mumps IgM can support the diagnosis.
- IgM is more likely detectable several days after symptom onset.
- In vaccinated patients, IgM may be absent, delayed, or transient.
- A negative IgM is therefore not sufficient to exclude mumps.
- IgG positivity mainly reflects past infection or vaccination and is not, by itself, proof of acute disease.
Other samples
- Urine, CSF, and blood may occasionally be tested in specific clinical contexts.
- In a patient with CNS disease, send CSF for routine cell count, glucose, protein, bacterial studies, and a viral workup guided by local protocols.
Exam answer:
In suspected mumps, take a buccal swab for rRT-PCR as soon as possible and serum for IgM. In a vaccinated patient, negative IgM or PCR does not reliably exclude mumps if clinical suspicion remains high.
8. Management
There is no specific proven antiviral therapy for uncomplicated mumps.
A. Uncomplicated mumps
Treatment is supportive:
- Oral fluids and nutrition
- Rest
- Paracetamol or NSAIDs for pain and fever, if appropriate
- Soft diet
- Avoid acidic foods and drinks if they worsen salivary pain
- Warm or cool compresses to swollen glands according to comfort
- Safety-net advice and review if complications develop
Do not give antibiotics unless bacterial parotitis or another bacterial infection is suspected.
Do not use corticosteroids routinely for uncomplicated mumps or orchitis.
B. Admit or urgently assess if there is
- Altered consciousness, seizures, focal neurology, or severe headache
- Meningism or suspected encephalitis
- Severe dehydration or inability to drink
- Severe abdominal pain or suspected pancreatitis
- Acute painful swollen testis, especially if torsion cannot be excluded
- Sudden hearing loss or severe vertigo
- Immunocompromise, severe comorbidity, or diagnostic uncertainty
9. Infection prevention and public health
Isolation
Use droplet precautions for 5 days after the onset of parotitis.
Practical measures:
- Keep the patient away from school, university, work, and healthcare duties during this period.
- Encourage cough hygiene and hand hygiene.
- Avoid sharing utensils, drinks, towels, or close face-to-face contact.
- In hospital, use a single room if feasible and droplet precautions.
Notification
Mumps is a notifiable disease in many countries. Notify local public-health authorities when suspected, not only after confirmation. They coordinate testing, contact tracing, exclusion advice, and outbreak measures.
Contacts
Management of contacts varies by country and outbreak protocol. Key points:
- Check evidence of immunity and MMR status.
- Bring those without adequate MMR vaccination up to date.
- MMR given after exposure does not reliably prevent mumps from that exposure, but it provides future protection.
- In an outbreak, public-health authorities may recommend a third MMR dose for people at increased risk who have already received two doses.
- There is no standard immune-globulin post-exposure prophylaxis for mumps.
10. Vaccination
Routine vaccination
Mumps vaccination is delivered as MMR, a live attenuated vaccine.
A common schedule is:
- First dose at 12-15 months
- Second dose at 4-6 years
Schedules vary by country, so use your national immunization programme for clinical decisions.
Vaccine effectiveness
Two doses substantially reduce mumps risk and complications, but are less protective than they are against measles. A commonly cited estimate is approximately 86-88% effectiveness after two doses. Goldman-Cecil Medicine, p. 3570.
Who should not receive MMR?
Major contraindications include:
- Pregnancy
- Severe immunodeficiency
- Previous anaphylaxis to a vaccine component or a prior dose
For women vaccinated with MMR, advise avoiding pregnancy for the interval specified by national guidance. MMR is not given during pregnancy, but inadvertent vaccination is generally not an indication for pregnancy termination.
Third dose
A third MMR dose is
not routine. It may be recommended during an identified outbreak for a group with increased exposure risk, such as students in an affected university. Its added protection may be short-term, which is why this is an outbreak-control measure rather than a universal booster strategy (
CDC guidance).
Bedside approach to a patient with suspected mumps
History
Ask about:
- Onset and progression of swelling
- Unilateral versus bilateral involvement
- Fever, headache, malaise, myalgia
- Pain when chewing or with acidic foods
- Contacts with parotitis or known mumps
- University, school, shared accommodation, team sport, military, prison, or outbreak exposure
- Travel
- MMR doses and dates, if known
- Testicular pain or swelling
- Pelvic pain or breast pain
- Headache, neck stiffness, photophobia, drowsiness, seizures
- Hearing loss, tinnitus, vertigo
- Abdominal pain and vomiting
- Immunocompromise and pregnancy status
Examination
Perform:
- Vital signs and hydration assessment
- Inspection and palpation of parotid, submandibular, and cervical areas
- Oral examination, including Stensen duct for pus
- Otoscopy if ear symptoms
- Full neurological examination if headache or altered sensorium
- Abdominal examination
- Genital examination if genital symptoms, with urgent torsion assessment where appropriate
- Hearing assessment at the bedside if auditory symptoms
Investigations
For most suspected cases:
- Buccal swab rRT-PCR
- Serum mumps IgM
- FBC, U&E, CRP only if clinically indicated, not to diagnose mumps
- Lipase if pancreatitis is suspected
- Urinalysis and STI testing if epididymo-orchitis is in the differential
- Urgent scrotal ultrasound if torsion is possible
- Lumbar puncture and neuroimaging guided by CNS presentation
High-yield viva questions
What is the most common clinical manifestation?
Parotitis, usually painful and often bilateral.
When is mumps infectious?
From 2 days before to 5 days after onset of parotitis.
What is the best confirmatory test?
Buccal-swab rRT-PCR, collected early after onset of parotitis.
How do you improve buccal-swab yield?
Massage the parotid gland for approximately 30 seconds before collecting the swab.
Does a negative IgM rule out mumps?
No, especially in vaccinated patients.
What is the most important complication in postpubertal males?
Orchitis.
What is the emergency differential diagnosis of mumps orchitis?
Testicular torsion.
What should you do immediately for suspected mumps in hospital?
Isolate with droplet precautions, send PCR/serology, and notify infection control/public health.
Is there an antiviral treatment?
No. Management is usually supportive.
Can vaccinated people get mumps?
Yes. Two doses reduce risk substantially but do not give complete protection.
Memory aid
MUMPS complications:
- Meningitis / meningoencephalitis
- Unilateral sensorineural hearing loss
- Male orchitis
- Pancreatitis
- Salivary-gland swelling
- Sterility is rare, but testicular atrophy/subfertility can occur
The central final-year message is:
Suspect mumps in acute parotitis even in vaccinated people. Isolate and notify early. Confirm with early buccal-swab rRT-PCR, do not over-rely on IgM, provide supportive treatment, and actively look for orchitis, CNS disease, pancreatitis, and hearing loss.
Textbook basis: Goldman-Cecil Medicine, pp. 3568-3570; Harrison’s Principles of Internal Medicine 22e, pp. 1690-1692; Medical Microbiology 9e, p. 778.